Abstract

Camptocormia is a common and often debilitating postural deformity in Parkinson’s disease (PD). Few treatments are currently effective. Deep brain stimulation (DBS) of the globus pallidus internus (GPi) shows potential in treating camptocormia, but evidence remains limited to case reports. We herein investigate the effect of GPi-DBS for treating camptocormia in a retrospective PD cohort. Thirty-six consecutive PD patients who underwent GPi-DBS were reviewed. The total and upper camptocormia angles (TCC and UCC angles) derived from video recordings of patients who received GPi-DBS were used to compare camptocormia alterations. Correlation analysis was performed to identify factors associated with the postoperative improvements. DBS lead placement and the impact of stimulation were analyzed using Lead-DBS software. Eleven patients manifested pre-surgical camptocormia: seven had lower camptocormia (TCC angles ≥ 30°; TCC-camptocormia), three had upper camptocormia (UCC angles ≥ 45°; UCC-camptocormia), and one had both. Mean follow-up time was 7.3 ± 3.3 months. GPi-DBS improved TCC-camptocormia by 40.4% (angles from 39.1° ± 10.1° to 23.3° ± 8.1°, p = 0.017) and UCC-camptocormia by 22.8% (angles from 50.5° ± 2.6° to 39.0° ± 6.7°, p = 0.012). Improvement in TCC angle was positively associated with pre-surgical TCC angles, levodopa responsiveness of the TCC angle, and structural connectivity from volume of tissue activated to somatosensory cortex. Greater improvement in UCC angles was seen in patients with larger pre-surgical UCC angles. Our study demonstrates potential effectiveness of GPi-DBS for treating camptocormia in PD patients. Future controlled studies with larger numbers of patients with PD-related camptocormia should extend our findings.

Details

Title
Pallidal stimulation as treatment for camptocormia in Parkinson’s disease
Author
Lai Yijie 1 ; Song Yunhai 2 ; Su Daoqing 3 ; Wang Linbin 1 ; Zhang Chencheng 1   VIAFID ORCID Logo  ; Sun Bomin 1 ; Nonnekes Jorik 4 ; Bloem, Bastiaan R 5 ; Li, Dianyou 1   VIAFID ORCID Logo 

 Shanghai Jiao Tong University School of Medicine, Department of Neurosurgery, Ruijin Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
 Shanghai Jiao Tong University School of Medicine, Department of Neurosurgery, Ruijin Hospital, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293); Shanghai Children’s Medical Center Affiliated to the Medical School of Shanghai Jiao Tong University, Neurosurgery Department, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293) 
 Liaocheng People’s Hospital and Liaocheng Clinical School of Shandong First Medical University, Department of Neurosurgery, Liaocheng, China (GRID:grid.415912.a) (ISNI:0000 0004 4903 149X) 
 Radboud University Medical Center, Donders Institute for Brain Cognition and Behavior, Department of Rehabilitation, Nijmegen, The Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382) 
 Radboud University Medical Center, Donders Institute for Brain Cognition and Behavior, Department of Neurology, Nijmegen, The Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
23738057
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2478661886
Copyright
© The Author(s) 2021. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.